Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | PNMT | P11086 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1777119 | 0.91 | GABRA1 (0.39) | GABRA1GABRB2SLC6A2TAAR1MAOA | |
| SCHEMBL1776725 | 0.87 | GABRA1 (0.36) | GABRA1GABRB2 | |
| SCHEMBL1777260 | 0.86 | GABRA1 (0.39) | GABRA1GABRB2SLC6A2TAAR1MAOA | |
| SCHEMBL1777957 | 0.84 | GABRA1 (0.38) | GABRA1GABRB2SLC6A2TAAR1MAOA | |
| SCHEMBL2698487 | 0.84 | GABRA1 (0.38) | GABRA1GABRB2SLC6A2TAAR1MAOA | |
| SCHEMBL1778239 | 0.84 | GABRA1 (0.34) | GABRA1GABRB2MAOA | |
| SCHEMBL1777118 | 0.81 | GABRA1 (0.35) | GABRA1GABRB2 | |
| SCHEMBL1777565 | 0.81 | KCNH2 (0.42) | SLC6A2SLC6A4SLC6A3ADORA2A | |
| SCHEMBL11503678 | 0.80 | GABRA1 (0.34) | GABRA1GABRB2 | |
| SCHEMBL20526185 | 0.78 | SLC6A2 (0.32) | GABRA1GABRB2SLC6A2TAAR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 528 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-07-04 | — | — | US | claimed |
| CN-117551134-A | Complex and preparation method and application thereof | 南京佳诺霖光电科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| WO-2024022413-A1 | DIVALENT METAL COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF, AND ORGANIC OPTOELECTRONIC DEVICE | 中国石油化工股份有限公司 | 2024-02-01 | — | — | WO | claimed |
| CN-117466944-A | Divalent metal complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2024-01-30 | — | — | CN | claimed |
| WO-2023196594-A2 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-10-12 | — | — | WO | claimed |
| CN-116574136-A | Bivalent platinum complex and preparation method and application thereof | 南京佳诺霖光电科技有限公司 | 2023-08-11 | — | — | CN | claimed |
| EP-3550657-B1 | ELECTROLYTE AND SECONDARY LITHIUM BATTERY | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-06-28 | — | — | EP | claimed |
| CN-115991724-A | Blue phosphorescence bivalent platinum complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-115991722-A | Yellow-green phosphorescence bivalent platinum complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-115991725-A | Green phosphorescence bivalent platinum complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| US-20090044863-A1 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | NATIONAL SCIENCE FOUNDATION | 2009-02-19 | — | — | US | claimed |
| US-20080223444-A1 | Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | GEORGIA TECH RESEARCH CORPORATION | 2008-09-18 | — | — | US | claimed |
| WO-2006093965-A2 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2006-09-08 | — | — | WO | claimed |
| CN-1247492-C | Cobalt catalyst composition for ethylene oligomerization and application thereof | CHINA NAT PETROLEUM CORP (CN) | 2006-03-29 | — | — | CN | claimed |
| WO-2005124453-A2 | PERYLENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2005-12-29 | — | — | WO | claimed |
| CN-1202049-C | Iron-based catalyst composition for ethylene oligomerization and application thereof | CHINA NAT PETROLEUM CORP (CN) | 2005-05-18 | — | — | CN | claimed |
| CN-1463800-A | Binuclear cobalt catalyst composition for synthesizing linear alpha-olefin by ethylene oligomerization and method for preparing linear alpha-olefin | PETROCHINA CO LTD (CN) | 2003-12-31 | — | — | CN | claimed |
| CN-1463799-A | Binuclear iron-based catalyst composition for preparing alpha-olefin by ethylene oligomerization and method for preparing linear alpha-olefin | PETROCHINA CO LTD (CN) | 2003-12-31 | — | — | CN | claimed |
| CN-1403424-A | Cobalt catalyst composition for ethylene oligomerization and preparation method of alpha-olefin | CHINA NAT PETROLEUM CORP (CN) | 2003-03-19 | — | — | CN | claimed |
| CN-1374281-A | Iron-based catalyst composition for ethylene oligomerization and preparation method of alpha-olefin | CHINA PETROLEUM CORP (CN) | 2002-10-16 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | FABP7, FFAR1, FABP1 | GABRA1 921/4885GABRB2 776/4885SLC6A2 188/4885 |
| US-20080223444-A1 | Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | SLC43A1, SLC3A2, SLC16A3 | GABRA1 3948/4885GABRB2 3158/4885SLC6A2 126/4885 |
| US-20090044863-A1 | CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | SLC18A3, CORO1C, SLC18A1 | GABRA1 3782/4885GABRB2 3009/4885SLC6A2 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.